bioMérieux – Endotoxin Testing (rFC) – Decoding the future of endotoxin testing
Express Pharma
JULY 11, 2025
After 50 years of LAL testing, the pharmaceutical industry is transitioning to recombinant Factor C (rFC) methods. USP Chapter <86> (November 2024) eliminates the biggest barrier—method validation—making adoption faster and easier than ever. It is now important to switch to recombinant methods than ever before!
Let's personalize your content